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Short Communication
Abstract
Scope: To characterize diet-dependent miRNA profiles and their targets in the visceral adipose of mice with 
polygenic susceptibility to type 2 diabetes. 
Methods and results: Six-week NONcNZO10/LtJ (NZ10) and control SWR/J mice were subjected to high 
protein-fish oil or control diets for 19 weeks and micro-RNA microarray analyses were implemented on visceral 
adipose RNA. We found that 27 miRNAs were significantly induced and 10 significantly repressed in the VA of 
obese NZ10 mice compared with controls. 12 selected regulated miRNAs were confirmed by RT-PCR based on the 
microarray data and we demonstrated that the expression of these miRNAs remained unaltered in the VA of control 
SWR mice. To assess the possible functional roles of miRNAs in adipogenesis, we also analyzed their expression 
in 3T3-L1 cells during growth and differentiation. This revealed that suppression of miRNA-205 alone correlated 
selectively with increased cell proliferation and lipid formation of adipocytes. 
Conclusion: Diet and genetics control the expression of obesity-regulated miRNAs in the visceral adipose of 
NZ10 mice.
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Introduction
Micro-RNAs (miRNAs) are short 21-23 nucleotide RNAs 
that regulate gene expression at the posttranscriptional level [1,2]. 
Obesity and insulin resistance are key features of type 2 diabetes. In 
obese individuals, increased adiposity is a consequence of increased 
number and size of adipocytes. The relative degree of hypertrophy 
versus hyperplasia influences the level of body fat and the metabolic 
consequences of obesity [3,4]. The involvement of miRNAs in 
adipocyte differentiation has been studied using 3T3-L1 cells wherein 
selective miRNAs have been assigned various roles in pre-adipocyte 
differentiation [5]. It is now known that several repressor miRNAs 
implicated in adipogenesis are inversely expressed in the obese adipose 
tissue [6] and this inverse regulatory pattern has been characterized 
in mouse models of obesity and in humans [7]. To date microRNA 
targets have only been identified in monogenic or diet-induced 
models of obesity and diabetes. These models involve severe obesity 
and hyperinsulinemia that is usually associated with hyperphagia 
and extreme leptin levels. There have been no reported studies on 
the regulation of microRNAs in polygenic models of obesity-induced 
diabetes. 
NONcNZO10/LtJ (NZ10) is a recombinant congenic strain for 
obesity-induced type 2 diabetes that was developed at The Jackson 
Laboratory (Bar Harbor, Maine). The polygenic nature with a 
maturity-onset transition from impaired glucose tolerance to a 
stable non-fasting hyperglycemia and a relatively mild obesity of the 
mice closely resembles human T2D. The NZ10 mice differ from the 
parent NZO/HILt strain in acquiring adiposity primarily in visceral 
rather than subcutaneous fat depots and this may contribute to the 
T2D-susceptibility phenotype [8]. Also, NZ10 mice accumulate more 
visceral fat and intramuscular triglyceride levels relative to wild type 
C57BI/6J mice subjected to either low or high fat (6 or 11%) diet [9]. 
We have recently reported that a high protein-fish oil diet prevents 
the development of obesity and type 2 diabetes in NZ10 mice and also 
influences visceral adipose remodeling by regulating the expression of 
matrix metalloproteinases and their inhibitors [10]. Here we report 
that miRNA-205 is selectively implicated in adipocyte division and 
lipid accumulation in vitro and in vivo.
Methods
Animals and diets
Four-week old male NZ10 mice and their non-diabetic SWR/J 
counterparts were purchased from The Jackson Laboratory (Bar 
Harbor, Maine). After 2 weeks of acclimatization mice were randomized 
into 2 groups (at least 10 mice per group) to receive control (CD) 
or High Protein-Fish Oil (HPO) diets for a period of 19 weeks [10]. 
Blood glucose after 12 hrs of fasting was measured with a glucometer 
(Freestyle, Abbott Diagnostics). For tissue harvest, mice were fasted for 
12-h, sacrificed by cervical dislocation and the visceral adipose depots 
including epididymal, perirenal, and retroperitoneal rapidly dissected 
and processed for RNA analysis. 
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MicroRNA microarrays
Pooled samples (n=5 per group) were homogenized in Trizol 
(Invitrogen, Carlsbad, CA) and total RNA was isolated. Quality of the 
total RNA samples was assessed using UV spectrophotometry and 
agarose gel electrophoresis. The samples were treated with DNAse 
and low-molecular weight (LMW) RNA isolated by ultrafiltration 
through YM-100 columns (Millipore) and subsequent purified using 
a RNeasy MinElute Clean-Up Kit (Qiagen, Valencia, CA). RNA 
samples were subjected to custom microarrays containing 374 probes 
covering mouse mature microRNAs present in Sanger 9.0 mirBASE 
at Ocean Ridge Biosciences (ORB, Palm Beach Gardens, FL). The 
species-specific, unmodified oligonucleotide probes are 34-44 bases in 
length from the Invitrogen Ncode Version 2.0 probe set (Invitrogen, 
Carlsbad, CA). The microarrays were produced by Microarrays Inc. 
(Huntsville, Alabama), and consisted of epoxide glass substrates 
spotted in triplicate with each probe. The LMW RNA samples were 
3’-end labeled with Oyster-550 fluorescent dye using the Flash Tag 
RNA labeling Kit (Genisphere, Hatfield, PA). Labeled LMW RNA 
samples were hybridized to the MicroRNA microarrays according to 
conditions recommended in the Flash Tag RNA labeling Kit manual. 
The microarrays were scanned on an Axon Genepix 4000B scanner, 
and data was extracted from images using GenePix V4.1 software. The 
data was preprocessed and normalized as described in Enquobahrie et 
al. [11].
Real time PCR 
MicroRNA expression levels were assayed by real time PCR using 
the ABI 7900HT thermal cycler with custom assays (Life Technologies, 
Grand Island, NY). PCR reactions were conducted at 95ºC for 10 
min and then followed by 40 cycles (15 s at 95ºC, 60 s at 60ºC). The 
following Assay IDs 000587, 000463, 002249, 002299, 000502, 002251, 
002300, 000507, 000509, 000546, 001077, 002607, 001670, 001678 and 
Mm01184322_m1were used for miRNAs -29c, 141, 143, 191, 200a, 
200b, 200c, 203, 205, 335, 429, 665, 685, 691 and PPARγ respectively. 
Eukaryotic 18S rRNA (Assay ID Hs99999901_s1) for PPARgamma 
gene expression and snoRNA 202 and 234 (Assay IDs 1232, 1234) for 
miRNA expression normalization were used. 
Cell culture 
Mouse 3T3-L1 preadipocytes were purchased from Zen-Bio 
(Research Triangle Park, NC) and were cultured in preadipocyte 
maintenance medium (PM-1-L1, Zen-Bio). For induction of 
adipogenesis the cultured preadipocytes were grown to 100% confluency 
and after 2 days the media was replaced with adipogenic differentiation 
medium (DM-2-L1, Zen-Bio). After 3 days the DM-2-L1 media was 
replaced by adipocyte maintenance medium (AM-1-L1, Zen-Bio). 
Adipocytes were fed with AM-1-L1 every 3rd day. Preadipocytes were 
transfected with pre or anti-miR-205 oligos (Life Technologies, Grand 
Island, NY) according to manufacturer’s instructions.
RNA isolation and reverse transcription 3T3-L1 cells
Total RNA was isolated from 3T3-L1 preadipocytes and adipocytes 
using miRVana kit (Life Technologies, Grand Island, NY). The 
concentration of RNA was determined by spectrophotometry, using 
Nanodrop-1000 (Nanodrop Technologies, Wilmington, DE). Reverse 
transcription for gene expression was performed on 200 ng/μl of RNA 
with High-Capacity cDNA Reverse Transcription kit using random 
primers (Life Technologies, Grand Island, NY). Reverse transcription 
for miRNA expression was performed on 10 ng of RNA with Taqman 
miRNA reverse transcription kit using custom primers for each miRNA 
(Life Technologies, Grand Island, NY).
Cell cycle proliferation
Cell proliferation of pre or anti-miR-205 transfected preadipocytes 
was measured using cell proliferation ELISA, BrdU colorimetric kit 
(Roche, Indianapolis, IN) as per manufacturer’s instructions. Briefly, 
3T3-L1 preadipocytes were transfected with Pre (10 μM)- or Anti-
miR-205 (10 μM) along with controls (transfection medium) in a 
96 well plate for 48 h followed by incubation with 10uM BrdU for 
2.5 h. The cells were then fixed and incubated with Anti-BrdU POD. 
Incubation with substrate was done for 20 minutes and the reaction 
was stopped using stop solution. Absorbance was measured using a 
plate reader at 450 nm. 
Oil red O staining
Preadipocytes were transfected with pre (10 μM) or anti-miR-205 
(10 μM) in 6 well plates. Oil Red O staining at Day 3 and Day 7 
visualized adipocytes formed. For Oil Red O staining the adipocyte 
maintenance medium was aspirated and cells were washed 3 times with 
phosphate buffered saline (PBS) and fixed with 4% paraformaldehyde 
for 30 minutes. After 30 minutes the paraformaldehyde solution was 
removed and cells were rinsed 3 times with PBS and twice with water. 
Oil red O solution was added and the cells were further incubated for 
50 minutes. After 50 minutes the stain was aspirated and cells were 
rinsed 3 times with water. The stained cells were photographed and 
dye extraction solution was added. The plate was set on an orbital 
shaker for 20 minutes and the extracted dye was transferred to a 96 
well plate and absorbance measured at 520 nm with a plate reader 
spectrophotometrically. Stain extracted from wells lacking cells 
represents non-specific binding of the dye to the plate and its value was 
subtracted from the absorbance of experimental wells.
Statistical analysis
Data are expressed as mean ± SEM. Differences between two 
groups were analyzed by Student’s “t” test and Mann-Whitney U test 
using Graphpad Prism 5.0. 
Results and Discussion
We recently reported that the HPO diet significantly reduced the 
body weight of NZ10 mice compared with their counterparts on CD 
or the SWR mice on either diet [10]. NZ10 mice fed CD had increased 
body fat and displayed hyperinsulinemia and fasting hyperglycemia 
that was not seen in mice fed HPO or SWR mice fed either diet [10]. 
These results confirm the development of a diabetogenic phenotype 
in NZ10 mice fed CD. NZ10 mice may be useful for identifying 
susceptibility loci and genetic background-diet interactions [12-14]. As 
a first step towards such analyses we implemented micro-RNA arrays 
using RNA from the VA of NZ10 and SWR strains fed CD or HPO 
diets as described [10]. miRNA microarray analysis of the VA revealed 
27 miRNAs that were significantly up-regulated and 10 miRNAs that 
were significantly down-regulated in the NZ10 mice fed HPO diet vs. 
those fed CD for 19 weeks (Figure 1, Tables 1-2). RT-PCR confirmed 
increased expression of 12 up-regulated miRNAs in the VA of NZ10 
mice fed HPO. Results from RT-PCR analyses of individual RNA 
samples are in good agreement with the microarrays (Figure 2, Table 
1-2). The HPO diet significantly up-regulated the expression of the 
miR-200 family as well as miRs- 143, 191 and 205 in the VA of NZ10 
mice but not in SWR mice suggesting complementary roles for diet and 
genetics in the regulation of these miRNAs (Figure 2). 
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Our results on the expression trends of the miR-200 family: miRs- 
200a, 200b, 200c, 141 and 429 are consistent with results reported 
previously using epididymal fat pads of DIO mice fed high fat diet 
[15]. Whereas, the expression of miR -148b was significantly inhibited 
in the VA of obese-diabetic NZ10 mice and the levels of miR-379 
previously reported to be up-regulated in the adipose of high fat fed 
DIO mice was also significantly induced in the VA of obese-diabetic 
NZ10 mice (Table 1). Similarly miRs- 1 and 122a were inhibited in 
the adipose of DIO mice and showed significant up-regulation in 
the obese NZ10 mice (Table 2) [15]. Another example of a miRNA 
showing differential expression patterns in the adipose of obese mice 
is miR-143. Its expression in the present study was significantly down-
regulated in the VA of obese-diabetic NZ10 mice fed CD compared to 
those fed HPO and unchanged in SWR mice (Figure 2). These results 
help resolve discrepancies in the literature where miR-143 has been 
shown to be unchanged [15], decrease [6], or increased [16] in parallel 
with obesity. The differences could be due to genetic background or 
different responses of miR-143 in different fat depots. 
Because members of miR-200 family and miR-205 showed 
significant inhibition in the VA of obese mice, we chose to evaluate 
whether any of these miRNAs are implicated in adipogenesis. We 
quantified the expression of miRs- 29c, 141, 191, 200a, 200b, 200c, 205, 
335 and PPARγ in 3T3-L1 cells at different stages of differentiation. 
MiRs- 200a, 200b and 141 were below levels of RT-PCR detection 
in 3T3-L1 cells either as preadipocytes or after differentiation into 
adipocytes. The levels of miRs- 29c, 191 and 200c increased up to Day 
3 and then reverted to preadipocyte levels by Day 7 (Figures 3a-3d). 
The trend was similar for miR-335 expression with a peak induction 
Figure 1: miRNA expression analysis of visceral adipose tissue using 
microarray analysis. Heat maps show differences in miRNA levels in the VA 
of NZ10 and SWR mice fed CD and HPO diet for 19 weeks. Inset heat map 
shows miRNAs significantly up-regulated by HPO diet only in the VA of NZ10 
mice and not the SWR mice of same age on either diet.
Figure 2: Real time PCR analysis of miRNAs revealed significant up-
regulation in the VA of NZ10 mice fed HPO over those fed CD (Purple Bars) 
and no change in expression of these miRNAs in VA of SWR mice fed any 
diet (Blue Bars). snoRNA-202 was used as an endogenous control and fold 
changes were calculated over CD fed mice.
microRNA ID NZ10 HPO/CD SWR HPO/CD
mmu-miR-100 4.3 0.8
mmu-miR-101a 3.5 1.3
mmu-miR-101b 3.4 0.6
mmu-miR-106a 7.5 1.2
mmu-miR-10a 6.8 1.0
mmu-miR-10b 7.5 1.2
mmu-miR-29c 4.4 0.5
mmu-miR-140* 5.4 0.6
mmu-miR-141 54.1 1.1
mmu-miR-143 2.2 1.2
mmu-miR-148a 20.3 0.9
mmu-miR-148b 4.6 0.6
mmu-miR-182 37.1 0.9
mmu-miR-187 3.7 1.4
mmu-miR-194 4.7 0.7
mmu-miR-200a 89.3 0.8
mmu-miR-200b 173.6 1.0
mmu-miR-200c 1555.7 1.1
mmu-miR-203 2.5 0.5
mmu-miR-204 26.8 1.2
mmu-miR-205 52.3 0.8
mmu-miR-375 145.7 1.0
mmu-miR-429 80.8 1.0
mmu-miR-542-5p 8.5 0.7
mmu-miR-665 4.9 2.1
mmu-miR-691 3.6 2.2
mmu-miR-744 34.6 4.5
Table 1: HPO diet up-regulated miRs in visceral adipose of NZ10 mice.
microRNA ID NZ10 HPO/CD SWR HPO/CD
mmu-miR-1 -3.4 -1.66
mmu-miR-122a -3.71 1.0
mmu-miR-199b -3.93 -1.42
mmu-miR-215 -6.81 9.9
mmu-miR-341 -3.45 -2.5
mmu-miR-342 -3.68 1.4
mmu-miR-379 -3.37 1.4
mmu-miR-483 -5.29 -2.5
mmu-miR-696 -4.16 -3.33
mmu-miR-702 -4.54 -5.0
Table 2: HPO diet down-regulated miRs in visceral adipose of NZ10 mice.
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Figure 3: miRNA expression as assessed by real time PCR at Day 0, 3 and 7 of 3T3-L1 preadipocyte differentiation. miRNA expression for Day 0, 3 and 7 are 
relative to the preadipocyte levels and snoRNA-234 and 18S rRNA were used as endogenous controls for normalization of miRNA and PPARgamma gene expression 
respectively. A schematic representation describing the 3T3-L1 adipogenesis paradigm for this study is provided in the supplement (Figure 1).
Figure 4: Lipid formation was assessed at Day 3 and Day 7 after miR-205 over-expression and inhibition in 3T3-L1 cells. (A) Oil red O staining at Day 3 revealed 
significantly increased lipid staining in the miR-205 inhibited cells compared to those over-expressing miR-205. (B) Spectrophotometric quantification of extracted oil 
red O stain (n=8 each group) at day 3. (C) Cell cycle proliferation was assessed in 3T3-L1 cells 48 hours after transfection with pre and anti-mIR-205 using BrdU elisa 
(n=8, each group).
Citation: Adi N, Adi J, Cesar L, Kurlansky P, Agatston A, et al. (2015) Role of Micro RNA-205 in Promoting Visceral Adiposity of NZ10 Mice with 
Polygenic Susceptibility for Type 2 Diabetes. J Diabetes Metab 6: 574. doi:10.4172/2155-6156.1000574
Page 5 of 5
Volume 6 • Issue 7 • 1000574J Diabetes Metab
ISSN: 2155-6156 JDM, an open access journal
at Day 3 followed by decline (Figure 3c). MiR-205 was unique insofar 
as its expression was significantly elevated at all-time points during 
adipogenesis in parallel with expression of the PPARγ gene (Figures 
3e,3d). By integrating separate datasets of genome wide PPARγ 
binding sites in 3T3-L1 cells John et al. [17] determined that miRs- 
103-1, 182/96/183, 205 and 378 are regulated by PPARγ. 
Results from our analyses reveal significant inhibition of miRs-182 
and 205 in the VA of obese NZ10 mice and increased expression of 
miR-205 in 3T3-L1 during adipogenesis (Figure 3e) [17]. This is the 
first study to show inhibition of miRs- 182 and 205 in VA of obese-
diabetic mice. The functions of these miRNAs in preadipocytes are 
still unknown. Because PPARγ levels are not induced in 3T3-1 cells 
until adipogenesis is induced [18] we chose to assess the role of miR-
205 independently of PPARγ in the preadipocyte stage. To this end 
we modified miR-205 expression in 3T3-L1 preadipocytes with either 
pre or anti-miRs and evaluated cell cycle proliferation. These results 
show a significant increase in preadipocyte proliferation by inhibition 
of miR-205 (Figure 4C). MiR-205 has been shown to target ErbB3 in 
cancer cells and it is known that ErbB3 is expressed in 3T3-L1 cells 
[19,20]. In addition to this upon adding the adipogenesis induction 
medium to 3T3-L1 cells after miRNA modulation and staining for lipid 
formation at Day 3, we found significantly increased oil red O staining 
in the miR-205 inhibited group (Figure 4A, 4B). We hypothesize that 
miR-205 targets ErbB3 in adipocytes and enhances proliferation; this 
in turn enhances adipogenesis and lipid production in cultured 3T3L-1 
cells after induction to differentiate. 
Conclusion
This is the first study to show diet-regulation of obesity-related 
miRNAs in a mouse model of polygenic susceptibility for obesity and 
type 2 diabetes. We show for the first time that miR-205 inhibition 
in 3T3-L1 preadipocytes increases cell proliferation and lipid 
accumulation after adipogenic induction. 
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